Tamarly Intelligence
Private raises · SEC Form D

Cadrenal Therapeutics, Inc.: $9 million Raised, SEC Form D Filings

Company · Biotechnology · FL · incorporated 2022 · SEC CIK 1937993 · Company page

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
15 Jul 2026New notice$9 million$9 millionBiotechnologyForm D
6 Apr 2026New notice$8 million$8 millionBiotechnologyForm D
31 Dec 2025New notice$4 million$4 millionBiotechnologyForm D

Questions and answers

How much has Cadrenal Therapeutics, Inc. raised?
Cadrenal Therapeutics, Inc. reported $9 million sold in its largest Form D notice on file; its latest notice was filed on 15 July 2026. Form D amounts are what the issuer reported to the SEC.
What is Cadrenal Therapeutics, Inc.?
Cadrenal Therapeutics, Inc. is a company in biotechnology, based in Ponte Vedra, Florida, incorporated in 2022, according to its SEC Form D filings.
How many Form D notices has Cadrenal Therapeutics, Inc. filed?
3 notices between 31 December 2025 and 15 July 2026 in Tamarly's record, which starts on 1 October 2025.
Get an alert when Cadrenal Therapeutics, Inc. files again, and see every Form D raise as it arrives; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "Cadrenal Therapeutics, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/1937993, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.